Foresite Capital Management V, LLC Pardes Biosciences, Inc. Transaction History

Foresite Capital Management V, LLC

  • $43.4 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$1.4 - $1.95 $1.08 Million - $1.51 Million
773,952 Added 7.71%
10,811,887 $19.6 Million
Q4 2022

Feb 13, 2023
BUY
$0.85 - $1.69 $541,807 - $1.08 Million
637,420 Added 6.78%
10,037,935 $17 Million
Q4 2021

Feb 11, 2022
BUY
$9.8 - $17.02 $92.1 Million - $160 Million
9,400,515 New
9,400,515 $154 Million

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Foresite Capital Management V, LLC Portfolio

Follow Foresite Capital Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management V, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email